1.09
-0.08 (-6.84%)
| 前收盘价格 | 1.17 |
| 收盘价格 | 1.15 |
| 成交量 | 4,490,533 |
| 平均成交量 (3个月) | 5,262,739 |
| 市值 | 216,036,928 |
| 预期市盈率 (P/E Forward) | 1.34 |
| 价格/销量 (P/S) | 0.870 |
| 股市价格/股市净资产 (P/B) | 98.42 |
| 52周波幅 | |
| 利润日期 | 11 Aug 2025 - 15 Aug 2025 |
| 营业毛利率 | -59.03% |
| 营业利益率 (TTM) | -34.00% |
| 稀释每股收益 (EPS TTM) | -0.850 |
| 季度收入增长率 (YOY) | -52.80% |
| 流动比率 (MRQ) | 1.18 |
| 营业现金流 (OCF TTM) | -100.11 M |
| 杠杆自由现金流 (LFCF TTM) | -80.85 M |
| 资产报酬率 (ROA TTM) | -7.17% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | Esperion Therapeutics, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.38 |
|
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 0.58% |
| 机构持股比例 | 59.30% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Meditor Group Ltd | 30 Sep 2024 | 3,791,300 |
| Indaba Capital Management, L.P. | 31 Mar 2025 | 3,000,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 16.00 (HC Wainwright & Co., 1,367.89%) | 购买 |
| 中 | 4.00 (266.97%) | |
| 低 | 3.00 (Goldman Sachs, 175.23%) | 保留 |
| 平均值 | 7.67 (603.67%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 0.970 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Jun 2025 | 16.00 (1,367.89%) | 购买 | 1.09 |
| 25 Apr 2025 | 16.00 (1,367.89%) | 购买 | 0.920 | |
| Needham | 07 May 2025 | 4.00 (266.97%) | 购买 | 0.870 |
| 25 Apr 2025 | 5.00 (358.72%) | 购买 | 0.920 | |
| Goldman Sachs | 17 Apr 2025 | 3.00 (175.23%) | 保留 | 0.950 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合